These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4356560)

  • 1. Failure of Bacillus Calmette-Guérin (BCG) infection to suppress the growth of transplanted mouse and rat sarcomas.
    Símová J; Bubeník J
    Folia Biol (Praha); 1973; 19(4):296-300. PubMed ID: 4356560
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB; Serrou B
    Cancer Res; 1976 May; 36(5):1731-4. PubMed ID: 773530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
    Baldwin RW; Pimm MV
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
    Takeuchi M; Kimoto M; Suzuki I; Nomoto K
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1980-6. PubMed ID: 6604499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of transplanted sarcomas mediated by BCG in rats with a defined immunological deficit.
    Moore M; Lawrence N; Nisbet NW
    Biomedicine; 1976 Jan; 24(1):26-31. PubMed ID: 773443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM; Riggs CW; Hanna MG
    Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
    Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
    Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
    Sparks FC; Breeding JH
    Cancer Res; 1974 Dec; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological reactivity of mice with transplanted lung tumors obtained via organ culture].
    Vlasov V; Uzunov P
    Eksp Med Morfol; 1984; 23(1):22-8. PubMed ID: 6088211
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour inhibition mediated by BCG in immunosuppressed rats.
    Moore M; Lawrence N; Nisbet NW
    Int J Cancer; 1975 Jun; 15(6):897-911. PubMed ID: 1150345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune status of the primary host toward its own methylcholanthrene-induced sarcomas.
    Stjernswärd J
    J Natl Cancer Inst; 1968 Jan; 40(1):13-22. PubMed ID: 5635014
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacillus Calmette-Guérin cell wall immunotherapy of intramuscular and metastatic Morris rat hepatomas.
    Wepsic HT; Tracey RS; Sell S; Harris S; Ribi E; Morris H
    Cancer Res; 1978 May; 38(5):1217-22. PubMed ID: 205358
    [No Abstract]   [Full Text] [Related]  

  • 15. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus Calmette-Guérin contact immunotherapy of local and metastatic deposits of rat tumors.
    Baldwin RW; Hopper DG; Pimm MV
    Ann N Y Acad Sci; 1976; 277(00):124-34. PubMed ID: 1069545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy.
    Miller CW; DeBlasi RF; Fisher SJ
    J Bone Joint Surg Am; 1976 Apr; 58(3):312-7. PubMed ID: 1063129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the effects of Bacillus Calmette-Guérin on Moloney sarcoma virus-induced tumors in normal and immunosuppressed mice.
    Houchens DP; Goldberg AI; Gaston MR; Kende M; Goldin A
    Cancer Res; 1973 Apr; 33(4):685-90. PubMed ID: 4696469
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.
    Bennett JA; Gruft H; McKneally MF; Zelterman D; Crispen RG
    Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.